Approximately 24,000 liver transplants are performed annually worldwide. Survival is excellent and continues to improve, with one-year survival currently exceeding 85%. Unfortunately, there remains a gap between the need for liver transplantation and the number of available donor organs. To close this gap, there is a need to innovative procurement and optimization of donor organs. This course will look at the impact of anti-HCV therapies, donation after cardiac death and perfusion strategies in donor organ availability. The course will also review the knowledge of liver transplant oncology (including out-of-Milan hepatocellular carcinoma) cholangiocarcinoma and colon cancer metastasis. Finally, the course will discuss ways attendees can ensure ongoing innovation and expanding the utility of transplantation.
Upon completion of this activity, participants will be able to: